awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30487077-297E1BF6-1F67-46E9-ABEF-185CCA7EEBCE
Q30487077-297E1BF6-1F67-46E9-ABEF-185CCA7EEBCE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30487077-297E1BF6-1F67-46E9-ABEF-185CCA7EEBCE
Assessing the clinical utility of cancer genomic and proteomic data across tumor types.
P2860
Q30487077-297E1BF6-1F67-46E9-ABEF-185CCA7EEBCE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30487077-297E1BF6-1F67-46E9-ABEF-185CCA7EEBCE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb8652d6996f24b8193b175254cb3397a02f149c
P2860
Phase II study of the MEK1/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor